Bio-Connect

InVivoMAb anti-mouse CD47 (IAP)

BE0270
Bio X Cell
ApplicationsImmunoFluorescence, Neutralisation/Blocking
Product group Antibodies
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Bio X Cell
  • Product Name
    InVivoMAb anti-mouse CD47 (IAP)
  • Delivery Days Customer
    7
  • Applications
    ImmunoFluorescence, Neutralisation/Blocking
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    MIAP301
  • Concentration
    4-11 mg/ml
  • Estimated Purity
    >95%
  • Host
    Rat
  • Isotype
    IgG2a
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • Pan Y, Lu F, Fei Q, et al. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer. J Hematol Oncol. 2019,12(1):124. doi: 10.1186/s13045-019-0822-6
    Read this paper
  • Reed M, Luissint AC, Azcutia V, et al. Epithelial CD47 is critical for mucosal repair in the murine intestine in vivo. Nat Commun. 2019,10(1):5004. doi: 10.1038/s41467-019-12968-y
    Read this paper
  • Liu M, O'Connor RS, Trefely S, et al. Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47-mediated 'don't-eat-me' signal. Nat Immunol. 2019,20(3):265-275. doi: 10.1038/s41590-018-0292-y
    Read this paper
  • Sallets A, Robinson S, Kardosh A, et al. Enhancing immunotherapy of STING agonist for lymphoma in preclinical models. Blood Adv. 2018,2(17):2230-2241. doi: 10.1182/bloodadvances.2018020040
    Read this paper
  • Wu L, Yu GT, Deng WW, et al. Anti-CD47 treatment enhances anti-tumor T-cell immunity and improves immunosuppressive environment in head and neck squamous cell carcinoma. Oncoimmunology. 2018,7(4):e1397248. doi: 10.1080/2162402X.2017.1397248
    Read this paper
  • Xu MM, Pu Y, Han D, et al. Dendritic Cells but Not Macrophages Sense Tumor Mitochondrial DNA for Cross-priming through Signal Regulatory Protein α Signaling. Immunity. 2017,47(2):363-373.e5. doi: 10.1016/j.immuni.2017.07.016
    Read this paper
  • Maute RL, Gordon SR, Mayer AT, et al. Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging. Proc Natl Acad Sci U S A. 2015,112(47):E6506-14. doi: 10.1073/pnas.1519623112
    Read this paper
  • Liu X, Pu Y, Cron K, et al. CD47 blockade triggers T cell-mediated destruction of immunogenic tumors. Nat Med. 2015,21(10):1209-15. doi: 10.1038/nm.3931
    Read this paper
  • Shi L, Bian Z, Chen CX, et al. CD47 deficiency ameliorates autoimmune nephritis in Fas(lpr) mice by suppressing IgG autoantibody production. J Pathol. 2015,237(3):285-95. doi: 10.1002/path.4574
    Read this paper
  • Hsieh CP, Chang WT, Lee YC, et al. Deficits in cerebellar granule cell development and social interactions in CD47 knockout mice. Dev Neurobiol. 2015,75(5):463-84. doi: 10.1002/dneu.22236
    Read this paper